摘要
通过系统梳理分析我国药品集中采购政策过程中的药品质量、药品供应、医疗机构与医生激励问题、患者信任问题、药品回款率问题、区域不平衡等方面的问题,提出通过完善价格机制、加强监测监管;加强资格审查,健全监管制度;发挥医保调节,加强“三医联动”;强化主体责任,保证回款效率;加强政策宣传,提升患者认知;扩大试点范围,规范集采流程等方面进一步优化药品集中采购政策。为进一步优化药品集中采购政策提供参考,为国家药品集中采购常态化、制度化,提供相关政策思考和建议.
By systematically sorting out and analyzing the problems of drug quality,drug supply,incentive problems of medical in-stitutions and doctors,patient trust,drug payback rate and regional imbalance in the process of China’s centralized drug procurement policy,it proposes to further optimize the centralized drug procurement policy by improving the price mechanism,strengthening moni-toring and supervision,strengthening qualification examination and improving the regulatory system,playing the regulation of medical insurance and strengthening the“Three Medical Linkage”;strengthen the main responsibility to ensure the efficiency of the return;strengthen policy publicity,enhance patient awareness;expand the scope of the pilot,standardize the collection process and other as-pects to further optimize the centralized drug procurement policy.References are provided for further optimization of centralized drug procurement policy,and relevant policy thinking and suggestions for the normalization and institutionalization of national centralized drug procurement.
作者
张玲
张娜
Zhang Ling;Zhang Na(China National Health Development Research Center,Beijing,100044,China;不详)
出处
《中国卫生经济》
北大核心
2023年第7期10-12,共3页
Chinese Health Economics
关键词
药品集中采购
政策实施
价格机制
监督管理制度
centralized drug procurement
policy implementation
price mechanism
supervision system